Biblio Discovery — Demo Discovery Service

10 hasil untuk "Federico Rodriguez-Porcel"

Menampilkan 1–10 · 0,52 detik · RSS

  1. Artikel Jurnal

    4302 Decreased structural basal ganglia motor loop connections in Vascular Parkinsonism compared to Parkinson’s disease and healthy aging

    Christine Cooper; Federico Rodriguez-Porcel; Travis Turner dkk.

    Journal of Clinical and Translational Science, Vol. 4 · 2020 · Inggris · DOAJ Scopus

    OBJECTIVES/GOALS: This study uses diffusion kurtosis imaging (DKI) to investigate the structural profiles of basal ganglia (BG) motor circuitry in Vascular Parkinsonism (VP), Parkinson’s disease (PD), and healthy aging controls (HC). VP is a clinical diagnosis of lower body predominant parkinsonism…

  2. Artikel Jurnal

    Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies

    Rachel J. Heo; Ahmed Negida; Kathryn A. Wyman‐Chick dkk.

    Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol. 11 No. 3 · 2025 · Inggris · DOAJ Scopus

    Abstract INTRODUCTION Current evidence supports the use of cholinesterase inhibitors (ChEIs) as the first‐line symptomatic treatment for improving cognition in dementia with Lewy bodies (DLB). Little is known about current prescribing patterns of ChEIs in DLB. This study aimed to identify the…

  3. Artikel Jurnal

    Movement Disorders in Prionopathies: A Systematic Review

    Federico Rodriguez-Porcel; Vinícius Boaratti Ciarlariello; Alok K. Dwivedi dkk.

    Tremor and Other Hyperkinetic Movements, Vol. 9 No. 0 · 2019 · Inggris · DOAJ Scopus

    Background: Movement disorders are frequent features of prionopathies. However, their prevalence and onset remain poorly described. Methods: We performed a systematic review of case reports and case series of pathologically- and genetically confirmed prionopathies. Timing of symptom and movement…

  4. Artikel Jurnal

    Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians

    Kathryn A. Wyman-Chick; Parichita Chaudhury; Ece Bayram dkk.

    Neurology and Therapy, Vol. 13 No. 3 · 2024 · Inggris · DOAJ Scopus

    Abstract This pragmatic review synthesises the current understanding of prodromal dementia with Lewy bodies (pDLB) and prodromal Alzheimer’s disease (pAD), including clinical presentations, neuropsychological profiles, neuropsychiatric symptoms, biomarkers, and indications for disease management…

  5. Artikel Jurnal

    A common outcome set for trials in dementia with Lewy bodies (DLB COS)

    Joseph P. M. Kane; Rachel L. Fitzpatrick; Sara Betzhold dkk.

    Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol. 11 No. 3 · 2025 · Inggris · DOAJ Scopus

    Abstract INTRODUCTION Methodological heterogeneity in dementia with Lewy bodies (DLB) trials contributes to publication bias and makes evidence synthesis and meta‐analysis challenging. We aimed to develop a core outcome set for DLB (DLB COS) trials to improve consistency and comparability in DLB…

  6. Artikel Jurnal

    Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

    Federico Rodriguez-Porcel; Kathryn A. Wyman-Chick; Carla Abdelnour Ruiz dkk.

    Translational Neurodegeneration, Vol. 11 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed…

  7. Artikel Jurnal

    Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care

    Brent Bluett; Alexander Y. Pantelyat; Irene Litvan dkk.

    Frontiers in Neurology, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS; the most common phenotype of corticobasal degeneration) are tauopathies with a relentless course, usually starting in the mid-60s and leading to death after an average of 7 years. There is as yet no specific or disease-modifying…